Status:
UNKNOWN
Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection
Lead Sponsor:
Bozyaka Training and Research Hospital
Conditions:
Recurrent Superficial Bladder Cancer
Distilled Water
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to compare and evaluate the efficacy of distilled water vs Mitomycin C on preventing the recurrences of intermediate risk group recurrent superficial bladder cancer admini...
Detailed Description
We plan to administer 200ml of distilled water as a single peroperative instillation and block the catheter for 2 hours to our eligible recurrent superficial bladder cancer patients who were in our fo...
Eligibility Criteria
Inclusion
- pathologic finding of superficial bladder cancer within the intermediate risk group
- recurred after 6 months from the primary tumor
- those patients who were included in our follow-up program since 2002 and whose records could be obtained.
Exclusion
- carcinoma in situ
- any form of intracavitary maintenance therapy
- any form of bladder cancer other than transitional cell type
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00816075
Start Date
February 1 2009
End Date
April 1 2011
Last Update
February 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bozyaka Training and Research Hospital Urology Clinic
Izmir, Turkey (Türkiye)